(Q39228836)

10 September 2017

1 reference

title

Regulation of the vasoactive intestinal peptide receptor (English)

1 reference

10 September 2017

Rosselin G

1

1 reference

10 September 2017

Anteunis A

2

1 reference

10 September 2017

Astesano A

3

1 reference

10 September 2017

Boissard C

4

1 reference

10 September 2017

Gali P

5

1 reference

10 September 2017

Hejblum G

6

1 reference

10 September 2017

Marie JC

7

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

Annals of the New York Academy of Sciences

10 September 2017

published in

1 reference

10 September 2017

volume

527

1 reference

10 September 2017

page(s)

220-237

1 reference

Vasoactive intestinal peptide

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Effector mechanisms of peptides of the VIP family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Design and biological activity of analogs of growth hormone releasing factor with potential amphiphilic helical carboxyl termini

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Regulation by secretin, vasoactive intestinal peptide, and somatostatin of cyclic AMP accumulation in cultured brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Rapid inhibition by somatostatin of vasoactive intestinal peptide-induced prolactin secretion by rat pituitary cells. Relationship to cyclic AMP accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Combined effects of vasoactive intestinal peptide and dopamine on adenylate cyclase in prolactin-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

VIP and noradrenaline act synergistically to increase cyclic AMP in cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Adrenergic versus VIPergic control of cyclic AMP in human colonic crypts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Modulation of cyclic AMP accumulation in GH3 cells by a phorbol ester and thyroliberin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Vasoactive intestinal polypeptide increases inositol phospholipid breakdown in the rat superior cervical ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Vasoactive intestinal peptide receptor on liver plasma membranes: characterization as a glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

VIP regulation of a human pancreatic cancer cell line: Capan-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

The postnatal development of VIP binding sites in rat forebrain and hindbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

Vasoactive intestinal peptide actions on cyclic AMP levels in cultured striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB26983.X

10.1111/J.1749-6632.1988.TB26983.X

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference